Lantheus Holdings (LNTH) Shares Repurchased (2024 - 2025)

Lantheus Holdings (LNTH) reported Shares Repurchased of $100.0 million for Q4 2025, little changed year-over-year from $100.0 million in Q4 2024, and little changed quarter-over-quarter from $100.0 million in Q3 2025.

Lantheus Holdings (LNTH) Shares Repurchased (2024 - 2025) Analysis & Trends

Lantheus Holdings (LNTH) has 2 years of Shares Repurchased data on file, last reported at $100.0 million in Q4 2025.

  • Shares Repurchased for Q4 2025 came in at $100.0 million, changed 0.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $300.0 million (changed N/A YoY), and the FY2025 annual result was $300.0 million, up 200.02% from the prior year.
  • Shares Repurchased steadied at $100.0 million in Q4 2025 per LNTH's latest filing, from $100.0 million in the prior quarter.
  • Over five years, Shares Repurchased peaked at $100.0 million in Q4 2025 and troughed at $100.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 606.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 1.50 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 54.00 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 27.70 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 100.02 Mn
Dec 31, 2025 100.02 Mn
Sep 30, 2025 100.00 Mn
Sep 30, 2025 100.00 Mn
Dec 31, 2024 100.00 Mn
Dec 31, 2024 100.00 Mn